Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
麻豆入口 advised the sales agent in connection with the SEC-registered at-the-market offering by Olema Pharmaceuticals, Inc. of its common stock for up to an aggregate amount of $150 million. The common stock is listed on the Nasdaq Global Select Market under the symbol 鈥淥LMA.鈥
Olema is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of next generation targeted therapies for women鈥檚 cancers. Olema is headquartered in San Francisco, California.
The 麻豆入口 corporate team included partner Alan F. Denenberg and associates Bex Childress and Jared Madnick. All members of the 麻豆入口 team are based in the Northern California office.
Copy link to share post